Evidence map›Paper›PMID 32976596›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2021

Mass Screening of Asymptomatic Persons for Severe Acute Respiratory Syndrome Coronavirus 2 Using Saliva.

Isao Yokota, Peter Y Shane, Kazufumi Okada, Yoko Unoki, Yichi Yang, Tasuku Inao, Kentaro Sakamaki, Sumio Iwasaki, Kasumi Hayasaka, Junichi Sugita and 3 more

Open access · bronzeAbstract readComment
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 102 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
102citing papers in PubMed, 9 pooled it
3.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

102 citing papers in PubMed, 9 syntheses or guidelines pooled it, 158 citations in OpenAlex.

  1. Pooled it
  2. SARS-CoV-2 saliva testing using RT-PCR: a systematic review.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

42 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Isao YokotaDepartment of Biostatistics, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Peter Y ShaneInternational Medical Department, Hokkaido University Hospital, Sapporo, Japan.
Kazufumi OkadaDepartment of Biostatistics, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Yoko UnokiDepartment of Biostatistics, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Yichi YangDepartment of Biostatistics, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Tasuku InaoDepartment of Biostatistics, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Kentaro SakamakiCenter for Data Science, Yokohama City University, Yokohama, Japan.
Sumio IwasakiDivision of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Sapporo, Japan.
Kasumi HayasakaDivision of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Sapporo, Japan.
Junichi SugitaDivision of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Sapporo, Japan.
Mutsumi NishidaDivision of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Sapporo, Japan.
Shinichi FujisawaDivision of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Sapporo, Japan.
Takanori TeshimaInternational Medical Department, Hokkaido University Hospital, Sapporo, Japan.ORCID 0000-0002-0941-271X
Hokkaido University · JPHokkaido University Hospital · JPYokohama City University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCoronavirus disease 2019 (COVID-19) has rapidly evolved to become a global pandemic, largely owing to the transmission of its causative virus through asymptomatic carriers. Detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in asymptomatic people is an urgent priority for the prevention and containment of disease outbreaks in communities. However, few data are available in asymptomatic persons regarding the accuracy of polymerase chain reaction testing. In addition, although self-collected saliva samples have significant logistical advantages in mass screening, their utility as an alternative specimen in asymptomatic persons is yet to be determined.

methodsWe conducted a mass screening study to compare the utility of nucleic acid amplification, such as reverse-transcription polymerase chain reaction testing, using nasopharyngeal swab (NPS) and saliva samples from each individual in 2 cohorts of asymptomatic persons: the contact-tracing cohort and the airport quarantine cohort.

resultsIn this mass screening study including 1924 individuals, the sensitivities of nucleic acid amplification testing with NPS and saliva specimens were 86% (90% credible interval, 77%-93%) and 92% (83%-97%), respectively, with specificities >99.9%. The true concordance probability between the NPS and saliva tests was estimated at 0.998 (90% credible interval, .996-.999) given the recent airport prevalence of 0.3%. In individuals testing positive, viral load was highly correlated between NPS and saliva specimens.

conclusionBoth NPS and saliva specimens had high sensitivity and specificity. Self-collected saliva specimens are valuable for detecting SARS-CoV-2 in mass screening of asymptomatic persons.

Indexed as

COVID-19SARS-CoV-2HumansMass ScreeningSalivaSpecimen HandlingCOVID-19LAMPPCRsalivaSARS-CoV-2

Identifiers

PMID32976596
PMCPMC7543374
OpenAlexW3088058747

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.